关注
Sanjida Ahmed Srishti
Sanjida Ahmed Srishti
Graduate School of Pharmaceutical Sciences, Duquesne University
在 duq.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Oncoinformatic screening of the gene clusters involved in the HER2-positive breast cancer formation along with the in silico pharmacodynamic profiling of selective long-chain …
AKMH Morshed, S Al Azad, MAR Mia, MF Uddin, TI Ema, RB Yeasin, ...
Molecular Diversity 27 (6), 2651-2672, 2023
312023
WGS-based screening of the co-chaperone protein DjlA-induced curved DNA binding protein A (CbpA) from a new multidrug-resistant zoonotic mastitis-causing Klebsiella pneumoniae …
MH Rahman, S Al Azad, MF Uddin, M Farzana, IA Sharmeen, KS Kabbo, ...
Molecular Diversity, 1-22, 2023
62023
Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared?
SM Ahmed, A Krishnan, O Karim, K Shafique, N Naher, SA Srishti, A Raj, ...
The Lancet Global Health 12 (10), e1706-e1719, 2024
12024
Rising pharmaceutical innovation in the Global South: a landscape study
M Vieira, T Andia, O Karim, SA Srishti, SA Pineda, A Alonso Ruiz, K Large, ...
Journal of Pharmaceutical Policy and Practice 16 (1), 155, 2023
12023
Pharmaceuticals research and development (R&D) in Bangladesh: ground realities and prospects
O Karim, SA Srishti, N Naher, SM Ahmed
BRAC James P Grant School of Public Health, BRAC University, 2023
12023
A review on CRISPR Technology as an Antiviral Tool
SA Srishti
Brac University, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–6